Search results
Results From The WOW.Com Content Network
Many investors define successful investing as beating the market average over the long term. But the risk of stock...
Athersys (ATHX) gains on encouraging results from its exploratory study on the intravenous administration of MultiStem cell therapy to treat patients suffering from ARDS.
While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.
The New York Stock Exchange reopened that day following a nearly four-and-a-half-month closure since July 30, 1914, and the Dow in fact rose 4.4% that day (from 71.42 to 74.56). However, the apparent decline was due to a later 1916 revision of the Dow Jones Industrial Average, which retroactively adjusted the values following the closure but ...
School closures and event cancellations prompted people to stock up on groceries. Long lines were seen at grocery stores and food pantries throughout the Portland metropolitan area. [40] Local cannabis dispensaries saw an increased demand as customers stocked up in case stores were forced to close temporarily. [41]
Investors need to pay close attention to Athersys (ATHX) stock based on the movements in the options market lately.
Across the first two days of August, the S&P 500 ( ^GSPC) slid 3.2% while the Nasdaq Composite ( ^IXIC) sank 4.7%. The moves extended a previous drawdown in the Nasdaq, with the index entering a ...
For premium support please call: 800-290-4726 more ways to reach us